Literature DB >> 21952910

Rhinocerebral mucormycosis--a case report.

Shaji Thomas1, V Dal Singh, Yuvaraj Vaithilingam, Sumeeth Cyriac Thayil, Rohit Kothari.   

Abstract

BACKGROUND: Rhinocerebral mucormycosis (RCM) is a rare, fulminating opportunistic fungal infection caused by a fungus of order Mucorales. These fungi are ubiquitus, subsisting on decaying vegetation and diverse organic material. Although fungi and spores of Mucorales show minimal intrinsic pathogenicity towards normal person, they can initiate aggressive and fulminating infection in immunocompromised host. Since RCM occurs infrequently, it may pose a diagnostic and therapeutic dilemma for those who are not familiar with its clinical presentation. CASE REPORT: We present a patient with classical presentation of RCM involving paranasal sinuses, orbit, and cranial base who was treated by combination of aggressive surgical and medical therapy. DISCUSSION: The purpose of this paper is to draw attention to the clinical presentation and pathogenesis of RCM and to emphasize need for high index of suspicion in diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952910     DOI: 10.1007/s10006-011-0292-7

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  10 in total

1.  Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: a case report.

Authors:  Stavros Tryfon; Ioannis Stanopoulos; Elias Kakavelas; Anastasia Nikolaidou; Ioannis Kioumis
Journal:  J Oral Maxillofac Surg       Date:  2002-03       Impact factor: 1.895

Review 2.  Rhinocerebral mucormycosis: an update.

Authors:  A Mallis; S N Mastronikolis; S S Naxakis; A T Papadas
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-11       Impact factor: 3.507

3.  Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.

Authors:  Stéphane Vigouroux; Odile Morin; Philippe Moreau; Françoise Méchinaud; Nadine Morineau; Béatrice Mahé; Patrice Chevallier; Thierry Guillaume; Viviane Dubruille; Jean-Luc Harousseau; Noël Milpied
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

Review 4.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

5.  Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.

Authors:  K Kulendra; M Habibi; C Butler; P Clarke; D Howard
Journal:  J Laryngol Otol       Date:  2010-04-14       Impact factor: 1.469

6.  Mucormycosis in immunochallenged patients.

Authors:  Jane Pak; Veronica T Tucci; Albert L Vincent; Ramon L Sandin; John N Greene
Journal:  J Emerg Trauma Shock       Date:  2008-07

7.  Invasive rhinocerebral mucormycosis with orbital extension in poorly- controlled diabetes mellitus.

Authors:  M H Hadzri; S M Azarisman; A R M Fauzi; A Kahairi
Journal:  Singapore Med J       Date:  2009-03       Impact factor: 1.858

8.  Liposomal amphotericin B treatment for rhinocerebral mucormycosis: how much is enough?

Authors:  Ophir Handzel; Zvi Landau; Doron Halperin
Journal:  Rhinology       Date:  2003-09       Impact factor: 3.681

9.  Rhinocerebral mucormycosis: An analysis of probable mode of spread and its implication in an early diagnosis and treatment.

Authors:  N S Kulkarni; A R Bhide; R S Wadia
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-04

Review 10.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.